Noel Gardner
Psychiatry · Salt Lake City, UTNPI 1285655746
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $438,300 of the $512,253 with a category attached, or 85.6%. AbbVie accounts for 93.1% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $137,101 and has fallen 87.5% since, to $17,168 in 2025. Among psychiatry clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 606 payments — averaging $845.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$477K
- Alkermes, Inc.$15K
- Takeda Pharmaceuticals U.S.A., Inc.$11K
- Acadia Pharmaceuticals Inc$9K
- Sunovion Pharmaceuticals Inc.$744
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$398
- plus $479 from 7 others
What the payments were for
- Consulting fees$13,9753%
- Speaking & faculty fees$438,30086%
- Travel & lodging$52,34910%
- Food & beverage$7,5491%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 527 | $476,906 |
| Alkermes, Inc. | 24 | $14,526 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $10,525 |
| Acadia Pharmaceuticals Inc | 14 | $8,676 |
| Sunovion Pharmaceuticals Inc. | 4 | $744 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $398 |
| Sage Therapeutics, LLC | 2 | $151 |
| Johnson & Johnson | 2 | $132 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $84 |
| Lundbeck LLC | 2 | $51 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$465,755
- LYBALVI$55,817
- TRINTELLIX$10,302
- NUPLAZID$8,380
- LATUDA$700
- ARISTADA$500
- ARISTADA INITIO$125
- CAPLYTA$125
- SPRAVATO$118
How this compares
$512,253 in reported general payments places this provider in the 95th percentile of 231 psychiatry providers in Utah.
Other psychiatry in Salt Lake City
- Frederick ReimherrSalt Lake City$18K
- Clark JohnsonSalt Lake City$7K
- Julian ThorneSalt Lake City$2K
- Benjamin ShapiroSalt Lake City$1K
- Mark NeumanSalt Lake City$1K
- Marc DavisSalt Lake City$736
- Sajid FaiziSalt Lake City$648
- Kylee JenkinsSalt Lake City$604
- Donna PhilippiSalt Lake City$377
- Joseph ReistetterSalt Lake City$306
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.